Press Releases

Press Releases

Date	Title	Format
November 17, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
November 15, 2021	Chinook Therapeutics Announces Closing of $183.5 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	PDF Version
November 9, 2021	Chinook Therapeutics Announces Pricing of an Upsized $160 Million Public Offering	PDF Version
November 8, 2021	Chinook Therapeutics Announces Proposed Public Offering of Common Stock	PDF Version
November 8, 2021	Chinook Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results	PDF Version
November 4, 2021	Chinook Therapeutics Presents Data from BION-1301 Phase 1/2 Trial in Patients with IgA Nephropathy (IgAN) and Atrasentan Program at the American Society of Nephrology (ASN) Kidney Week 2021	PDF Version
October 15, 2021	Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the American Society of Nephrology (ASN) Kidney Week 2021	PDF Version
September 20, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
September 2, 2021	Chinook Therapeutics to Present at Upcoming Investor Conferences	PDF Version
August 12, 2021	Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results	PDF Version

Email Alerts

Investors